Genmab Announces Development Plans for Ofatumumab
PharmaLive.com (press release) - Newtown,PA,USA
We also plan to expand the development program with initiation of a Phase II study in relapsing remitting multiple sclerosis (RRMS) in the first quarter of ...
See all stories on this topic